CORE LABORATORIES INC (CLB)
Energy · oil and gas equipment and services · NYSE
Core Laboratories provides specialized laboratory analysis and technology-driven services to help oil and gas companies maximize production and recovery from their reservoirs.
What CORE LABORATORIES INC does
Core Laboratories provides reservoir description, reservoir management, and reservoir enhancement services and products to the oil and gas industry. The company assists clients in optimizing hydrocarbon recovery from their producing fields through advanced technologies and laboratory analysis. Its operations span the global upstream energy market, focusing on both conventional and unconventional oil and gas reservoirs.
Themes: reservoir optimization, enhanced oil recovery (EOR), upstream energy services, hydrocarbon production efficiency
Fundamentals
- Price$10.16 as of 2026-10-08 close
- Market cap$466M as of 2026-07-24 (share count; price 2026-10-08)
- 1-year return-15.9% 2025-10-08 close $12.08 → 2026-10-08 close $10.16
- P/E19.54 as of 2026-10-08
- Net margin+5.6% FY2025, SEC XBRL
- ROE+10.9% FY2025, SEC XBRL
- Debt / equity0.42 as of 2026-09-03
- Revenue growth (YoY)+0.3% as of 2026-09-03
- Revenue CAGR (3y)+2.4% SEC XBRL
- Beta1.39 as of 2026-09-03
- Last reported earnings2026-07-29 SEC EDGAR Form 8-K (Item 2.02)
Dividend: yield +0.4%; at least 5 years of non-decreasing per-share dividends (SEC XBRL) — we do not hold the year before it, so the real streak may be longer.
How CLB compares in its sector
- price-to-earnings ratiomiddle range 108 covered Energy peers, as of 2026-10-08
- net profit marginmiddle range 135 covered Energy peers, as of 2026-09-03
- operating marginmiddle range 122 covered Energy peers, as of 2026-09-03
- return on equitymiddle range 143 covered Energy peers, as of 2026-09-03
- 3-year revenue CAGRmiddle range 137 covered Energy peers
- indicated dividend yieldbottom 10% 101 covered Energy peers, as of 2026-09-03
- free cash flow (absolute dollars, latest fiscal year)middle range 94 covered Energy peers, as of FY2025
Position among covered Energy companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Dividend coverage (FY2025)
Covered by reported results. In FY2025, CLB's dividend was covered by reported results (earnings payout 6%, free-cash-flow payout 7%). This describes past coverage, not a forecast.
- Earnings payout6% dividends / net income
- Free-cash-flow payout7% dividends / (operating cash flow − capex)
Coverage derived from reported SEC EDGAR XBRL figures for FY2025 (dividends paid vs. net income and free cash flow, same fiscal year). This describes PAST coverage for one fiscal year — it does not predict whether a dividend will be maintained, raised, or cut, and a one-year payout ratio can be distorted by non-recurring items. Informational only — not financial advice.
How CORE LABORATORIES INC looks technically
CORE LABORATORIES INC (CLB) is trading 29.9% below its 200-day average, the long-term trend line — a long-term downtrend. Its 50-day average crossed below its 200-day average about 88 trading days ago — a "death cross", a bearish long-term signal. A strong downtrend is in place — ADX, a 0–100 trend-strength gauge, is 35, with sellers in control. Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 36, neither overbought (above 70) nor oversold (below 30). It made a new 20-day low about 7 trading days ago. It is 50.0% below its highest point of the past year.
Trend
7
| Distance from the 200-day | it is trading 29.9% below its 200-day average, the long-term trend line — a long-term downtrend | -29.9% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $11.53 | $11.53 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $14.49 | $14.49 |
| Swing structure | its recent peaks and dips disagree — one of them is rising while the other is not, so there is no clean up or down pattern in the swings | mixed — one of the two is not confirming |
| Last swing turn | its last significant turn was a swing low 8 calendar days ago — the swings before that are what the structure reading is measured on | 8 sessions |
| Since the 50/200 cross | its 50-day average crossed below its 200-day average about 88 trading days ago — a "death cross", a bearish long-term signal | 88 sessions |
| Trend strength (14-day ADX) | a strong downtrend is in place — ADX, a 0–100 trend-strength gauge, is 35, with sellers in control | 35.1 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 36, neither overbought (above 70) nor oversold (below 30) | 36.2 |
|---|---|---|
| Position in its 14-day range | it is trading in the lower half of its 14-day range ($9.63 to $11.31) — its "stochastic" reading is 32 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 31.6 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, is in negative territory (momentum leaning bearish) | 21 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $20.31 | $20.31 |
|---|---|---|
| From the 52-week high | it is 50.0% below its 52-week high (its highest price of the past year) | -50.0% |
| Above the 52-week low | it is 5.5% above its 52-week low (its lowest price of the past year) | +5.5% |
| Below the 52-week high | it is 50.0% below its highest point of the past year | 50.0% |
| Since a 20-day breakout | it made a new 20-day low about 7 trading days ago | 7 sessions |
| Since a 55-day breakout | it made a new 55-day low about 7 trading days ago | 7 sessions |
| All-time high | its highest closing price on record is $221.00 (set on 2014-04-17) | $221.00 |
| Given back of the 52-week move | over the past year its closes ranged ($9.70 to $19.67), and it has recovered only a small part of its fall from last year’s high — 5% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $15.86 to $16.18. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 4.6% |
| From the all-time high | it is 95.4% below its all-time high | -95.4% |
| Nearest price level | it is sitting right on a resistance level at $10.19 — a price it turned at three times since 2025-04-09, most recently on 2025-10-13. Since 2024-10-08 it has 1 such level below the current price and 18 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | +0.3% |
| All-time low | its lowest closing price on record is $6.68 (set on 2020-03-18) | $6.68 |
| Above the all-time low | it is 52.1% above its all-time low | +52.1% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are wider than usual versus its own recent 6-month history (wider than about 79% of it) | 79th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $0.4385 between its high and its low — about 4.3% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $0.4385 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $9.04 and $12.43 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $9.04 – $10.73 – $12.43 |
| Typical daily range (% of price) | its price moves about 4.3% in a typical session — about typical for the companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 4.3% |
| Stretch from the 200-day average | it is trading 9.9 daily ranges below its 200-day average price (29.9% below it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 9.9 daily ranges below its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.89× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
1
| Since a doji | today it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | today |
|---|
Price gaps
1
| Gap at the open | it opened on 2026-10-08 0.6% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | +0.6% |
|---|
Price streaks
1
| Closing streak | it closed higher in its latest session, after a session that did not close higher — a single up day rather than a run | 1 session up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock lagged the market by 19.6 percentage points (the stock lost 18.5% while the market gained 1.0%) | -19.6% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 12.7 percentage points (the stock lost 8.9% while the market gained 3.8%) | -12.7% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 56.3 percentage points (the stock lost 38.8% while the market gained 17.5%) | -56.3% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 30.9 percentage points (the stock lost 15.9% while the market gained 15.0%) | -30.9% |
Signal agreement
2
| Bullish technical signals | 0 of the 9 technical signals we can compute for it are currently in a bullish state — these describe past price behaviour, not a forecast | 0 of 9 |
|---|---|---|
| Bearish technical signals | 6 of the 9 technical signals we can compute for it are currently in a bearish state: a "death cross" — its 50-day average is below its 200-day, trading below its 200-day average, MACD momentum is negative, a strong downtrend, with sellers in control, lagging the market over 6 months, trading below the Ichimoku cloud — these describe past price behaviour, not a forecast | 6 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 10% below the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-09-01 and projected forward over today's price, the side traders read as an established downtrend, with the band above acting as the level that would have to be cleared. The band itself is moderate, spanning 4.8% of the share price. | -10.3% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 24% below the average price paid so far this year, so the typical buyer over that stretch is under water. That average is $13.30 — a volume-weighted average of daily closes over 191 sessions, not a true tick-by-tick VWAP. | -23.6% |
|---|---|---|
| Vs the average paid since it last reported | the price is 10% below the average price paid since it last reported on 2026-07-29 (its 8-K), so the typical buyer over that stretch is under water. That average is $11.25 — a volume-weighted average of daily closes over 51 sessions, not a true tick-by-tick VWAP. | -9.7% |
Double bottom, bullish — forming · entry $12.65 · 50 sessions in
Price levels it has turned at before
CLB last closed at $10.16 on 2026-10-08. Since 2024-10-08 it has turned at 1 price below its last close and 18 above; the nearest below and the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $10.19 | Resistance | 0.3% above the last close | turned there three times · 2025-04-09 to 2025-10-13 |
| $10.51 | Resistance | 3.4% above the last close | turned there twice · 2025-06-03 to 2026-06-25 |
| $9.71 | Support | 4.4% below the last close | turned there three times · 2025-08-11 to 2026-09-30 |
| $11.10 | Resistance | 9.2% above the last close | turned there three times · 2025-04-30 to 2025-07-17 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
No Elliott-wave labelling currently fits its swings: the recent highs and lows do not satisfy the three rules a five-wave count has to obey, so there is no count to show rather than a count we are unsure about.
Read from daily closes as of 2026-10-08.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading below the 200-day moving average · Pulled back from the 12-month high · lagging the market · Printed a doji candle · Stretched far below its 200-day average (6+ daily ranges) · Under water since its last earnings report (below the anchored VWAP) | Learn: moving average · golden cross · adx · rsi · breakout · fifty two week high low
Based on daily closing prices as of 2026-10-08. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingBuy (2.33 mean, 1=Strong Buy…5=Strong Sell) — 3 analysts
- Mean price target$15.00 range $11.00 – $21.00; median $13.00
Analyst estimates, as of 2026-10-07. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for CLB
- Consensus EPS estimate$0.16 next reporting period, as of 2026-10-07
- Estimate change, 30 days+$0.00667 (+4.4%) from $0.1533, on 2026-09-02, 35-day window
- Readings revised upward13% of 8 comparable readings
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["volatility in global oil and gas prices and capital expenditures","geopolitical instability in regions where the company operates","reliance on continued customer demand for advanced reservoir optimization technologies"]
What changed in the latest 10-Q
AI-assisted comparison of CLB's 10-Q filed 2026-07-30 against the prior one filed 2026-05-01.
Management's Discussion & Analysis (MD&A)
- Reworded:
- The newer filing (2026-07-30) states the financial position is summarized 'as of June 30, 2026', while the older filing (2026-05-01) states 'as of March 31, 2026'.
- Notes:
- Both source texts appear truncated at the end, ending mid-sentence in the forward-looking statements section with 'see Part II, "'
- The comparison is limited to the MD&A sections provided; other sections of the filings were not included in this comparison.
Risk Factors
- Added:
- Newer filing (2026-07-30) adds: 'and action by other military groups' to describe retaliation against United States and Israeli interests, and specifies 'including merchant vessels' as targets.
- Newer filing (2026-07-30) adds a paragraph on U.S. onshore market expectations: 'As such, we expect changes in crude oil prices will marginally improve drilling and completion activity levels in the U.S. onshore market which could directly affect demand for our well completion services and products.' (former text said changes would have 'a greater impact').
- Newer filing (2026-07-30) adds 'and the Middle East' to the list of notable larger project locations along with 'sell perforating systems and well diagnostic services in every major producing region of the world.'
- Newer filing (2026-07-30) adds: 'The uncertainty related to the Strait of Hormuz and more recently the Red Sea with the onset of military conflict in Iran has further exacerbated maritime trade flows of crude oil and derived products.'
- Newer filing (2026-07-30) adds: 'These disruptions resulted in a reduction of 15% to 20% in the global cargo movement of crude oil and derived products during the second quarter of 2026 compared to the same period in the prior year.'
- Newer filing (2026-07-30) adds: 'Accordingly, the full impact of these events on our business is not known at this time.'
- Removed:
- Older filing (2026-05-01) contained an opening paragraph on OPEC+ supply restrictions, production increases, and potential crude oil surplus, which was removed in the newer filing.
- Older filing (2026-05-01) contained: 'Recently, revised IEA field data showed that a steeper natural decline rate may represent a dominant long-term supply risk, where the agency projected a sustained upstream investment of approximately $540 to $570 billion per year is required to prevent disruptive declines and to avoid supply shortages and price volatility.' This sentence was removed in the newer filing.
- Older filing (2026-05-01) contained: 'Although demand for the Company's laboratory assay services continued to increase during 2025, geopolitical conflict and associated sanctions continue to create a higher level of uncertainty.' This sentence was removed in the newer filing.
- Reworded:
- Newer filing (2026-07-30) says 'situation throughout the region remains volatile' (same as older), but changes 'retaliation by Iran against United States and Israeli interests' to 'retaliation by Iran and action by other military groups against United States and Israeli interests, including merchant vessels'.
- Newer filing (2026-07-30) changes 'we expect changes in crude oil prices will have a greater impact on drilling and completion activity levels' to 'we expect changes in crude oil prices will marginally improve drilling and completion activity levels'.
- Newer filing (2026-07-30) changes 'United States, Israel and Iran' to 'United States and Iran' in describing ongoing geopolitical conflicts.
- Newer filing (2026-07-30) changes 'such as diesel fuel' to 'such as fuels' when describing disrupted crude oil and derived products trading.
- Newer filing (2026-07-30) changes 'The effective closure of the Strait of Hormuz' to 'The uncertainty related to the Strait of Hormuz and more recently the Red Sea'.
- Newer filing (2026-07-30) changes focus description from 'large-scale core analyses and reservoir fluids characterization studies in most oil-producing regions across the globe, which include both newly developed fields and brownfield extensions in many offshore developments in both the U.S. and internationally' to 'large-scale core analyses and reservoir fluids characterization studies in most oil-producing regions across the globe, which include both newly developed fields and brownfield extensions in both the U.S. and internationally'.
- Newer filing (2026-07-30) changes U.S. project description to include 'Alaska' in addition to 'onshore unconventional basins and offshore projects in the Gulf of Mexico'.
- Newer filing (2026-07-30) changes 'Outside the U.S. we continue to work on many smaller and large-scale projects analyzing crude oil and derived products in every major producing region of the world' to 'Outside the U.S., we continue to work on many small and large-scale projects analyzing rock, reservoir fluids, and crude oil and derived products and sell perforating systems and well diagnostic services in every major producing region of the world'.
- Newer filing (2026-07-30) changes 'despite the geopolitical conflicts mentioned above' to 'unless directly impacted by the conflicts mentioned above' in the sentence about international projects being executed as planned.
- Notes:
- Both filings contain a section titled 'Results of Operations' with financial tables. The newer filing presents three months ended June 30, 2026 versus June 30, 2025 and March 31, 2026. The older filing presents three months ended March 31, 2026 versus March 31, 2025. These are different reporting periods and not directly comparable line-by-line.
- The older filing's financial table is truncated at 'Debt to Adjusted EBITDA ratio (3) is calculated as follows: debt less cas...' and does not include the full completed section.
- The newer filing's financial table is truncated mid-table after the Interest expense line for the March 31, 2026 comparison.
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
1 open-market purchase and 0 open-market sales by insiders in the last 90 days, of which we have read Form 4 filings through 2026-10-04. The 5 days since 2026-10-04 have not been checked yet.
- Last 90 days · read to 2026-10-041 buy ($53900) · 0 sells — 1 buying insider
- Last 180 days · read to 2026-10-041 buy ($53900) · 0 sells — 1 buying insider
Activity heuristic: net buying (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-07-31. Based on Form 4 filings read through 2026-10-04; anything filed since is not yet included.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about CLB's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
5 institutional 13F filers reported holding CLB as of 2026-06-30 (quarter-end position, filed within 45 days).
- Distinct 13F filers 5
- Reported shares held 10,419,416
- Reported value $121,386,186
reported quarterly holdings change (2026-03-31 → 2026-06-30): 0 new, 3 increased, 2 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Ask about CLB's institutional holders → See what each manager we track holds →
Short interest (FINRA)
CLB had 4,382,706 shares of reported short interest as of the 2026-09-15 FINRA settlement date (delayed, bi-monthly; not real-time).
CLB had 9.55% of its shares outstanding sold short as of the 2026-09-15 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 10.24 days to cover at the same settlement.
- Reported short interest (shares) 4,382,706
- Short interest (% of shares outstanding) 9.55%
- Prior settlement (shares) 4,095,677
- Reported change 7.01%
- Days to cover (reported) 10.24
Reported to FINRA as of the 2026-09-15 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Schlumberger (SLB)
- Halliburton (HAL)
- Baker Hughes (BKR)
- Weatherford International (WFRD)
- TechnipFMC (FTI)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare CLB vs…
Frequently asked questions
What does CORE LABORATORIES INC (CLB) do?
Core Laboratories provides reservoir description, reservoir management, and reservoir enhancement services and products to the oil and gas industry. The company assists clients in optimizing hydrocarbon recovery from their producing fields through advanced technologies and laboratory analysis. Its operations span the global upstream energy market, focusing on both conventional and unconventional oil and gas reservoirs.
What sector is CORE LABORATORIES INC (CLB) in?
CORE LABORATORIES INC (CLB) is classified in the Energy sector. Its industry is oil and gas equipment and services. It trades on NYSE.
Does CLB pay a dividend?
Yes — CORE LABORATORIES INC (CLB) pays a dividend, with an indicated yield of about 0.36% and at least 5 years of non-decreasing per-share dividends (SEC EDGAR XBRL) — we do not hold the year before it, so the real streak may be longer (market data, as of 2026-09-03). Informational only — not financial advice.
Who are CORE LABORATORIES INC's (CLB) competitors?
Notable peers of CORE LABORATORIES INC (CLB) include Schlumberger, Halliburton, Baker Hughes, Weatherford International and TechnipFMC. This peer set is informational only — not financial advice.
Is CORE LABORATORIES INC (CLB) overbought or oversold right now?
CORE LABORATORIES INC (CLB) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 36, in the neutral middle (as of 2026-10-08). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on CLB come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest; prices are market data, as of 2026-09-03; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.